Download tb medical consultant`s meeting

TB MEDICAL CONSULTANT’S MEETING
NOVEMBER 9-10, 2011
CME CERTIFIED ACTIVITY
Course Location
New Jersey Medical School Global Tuberculosis Institute
225 Warren St. 1st Floor
Newark, New Jersey
Sponsored By
University of Medicine & Dentistry of New Jersey (UMDNJ), New Jersey Medical School
Global Tuberculosis Institute, and UMDNJ-Center for Continuing and Outreach Education
The New Jersey Medical School Global Tuberculosis Institute is the tuberculosis Regional Training and Medical Consultation
Center for the northeastern United States
This activity is supported by an educational grant from the Centers for Disease Control and Prevention,
Division of Tuberculosis Elimination
WHY COURSE IS NEEDED
As the incidence of TB continues to decline, maintaining clinical expertise is particularly challenging.
Therefore, ongoing training and education are important for clinicians so they can develop and enhance
skills in the diagnosis of TB, follow recommended treatment guidelines, and interact effectively with
public health agencies.
COURSE DESCRIPTION & OVERALL GOAL
This meeting will provide an opportunity to discuss current and emerging TB issues, as well as the
management of routine and complicated TB cases.
COURSE REQUIREMENTS
In order to meet the learning objectives and receive continuing education credits, participants are
required to attend the entire meeting, and complete an evaluation form and a follow up evaluation
within 2 months of the meeting.
WHO SHOULD ATTEND
This meeting is designed for physicians who serve as TB medical consultants for TB programs in the
Northeastern Region of the United States. Physicians who provide TB medical consultation may also
attend.
OBJECTIVES
Upon completion of this workshop, participants will be able to:
• Apply current approaches for the diagnosis, treatment and management of routine and complex
TB cases
• Describe the importance of emergency departments in the early diagnosis of TB and prevention of
spread to the community
• Review the diagnostic and therapeutic challenges of TB during pregnancy
• Discuss the risk of TB and challenges in the clinical management for patients who take anti-TNF
alpha therapeutic agents
FACULTY LIST
Elissa Schecter-Perkins, MD – Assistant Professor of Emergency Medicine
Boston University School of Medicine
Sundari Mase, MD – Team Lead for Medical Affairs, Field Services & Evaluation Branch
Centers for Disease Control & Prevention – Division of TB Elimination
John Jereb, MD – Medical Epidemiologist
Centers for Disease Control & Prevention – Division of TB Elimination
Alfred Lardizabal, MD – Associate Director
NJMS Global Tuberculosis Institute
Lee Reichman, MD – Executive Director
NJMS Global Tuberculosis Institute
Chia-Ling Nhan Chang, MD – Assistant Clinical Professor of Obstetrics & Gynecology
New York Presbyterian Hospital
Anne Fanning, MD – Professor Emeritus, Division of Infectious Diseases
University of Alberta Centenary
Eugenio Capitle, MD – Assistant Professor
UMDNJ – New Jersey Medical School
PLANNING COMMITTEE
New Jersey Medical School Global TB Institute
Nisha Ahamed, MPH – Program Director, Education & Training
Anita Khilall, MPH – Senior Training & Consultation Specialist
Alfred Lardizabal, MD – Associate Director
Eileen Napolitano – Deputy Director
Lee Reichman, MD – Executive Director
AGENDA
Wednesday, November 9, 2011 – The Newark Club
1:00 pm
Program Overview – Lee Reichman, MD, MPH
2:00 pm
Keynote Address – Anne Fanning, MD
3:00 pm
TB in Emergency Department Settings – Elissa Schecter-Perkins, MD
3:30 pm
Break
3:45 pm
TB in the Pregnant Patient – Chia-Ling Nhan-Chang, MD
4:15 pm
Management of TB in Patients on TNF-Alpha Antagonists
– Eugenio Capitle, MD
4:45 pm
Panel Discussion
6:00 pm
Adjourn
Thursday, November 10, 2011 – NJMS Global Tuberculosis Institute
8:30 am
9:00 am
9:30 am
10:30 am
10:45 am
11:15 pm
Continental Breakfast
A Year in Review: RTMCC Medical Consultation
– Alfred Lardizabal, MD & Sundari Mase, MD
Case Presentations & Discussion
– Moderator: Alfred Lardizabal, MD
Break
Prevent TB: 3HP for Treatment of LTBI – John Jereb, MD
Questions & Discussion
– Moderator: Lee Reichman, MD
12:00 pm
1:00 pm
2:00 pm
3:30 pm
4:15 pm
4:30 pm
Lunch
Case Presentations & Discussion
– Moderator: Alfred Lardizabal, MD
TB Expert Network Conference hosted by CDC
- Moderator: Sundari Mase, MD, MPH
Case Presentations & Discussion
– Moderator: Lee Reichman, MD
Wrap Up & Evaluation
Adjourn
CONTINUING EDUCATION INFORMATION
UMDNJ – Center for Continuing and Outreach Education is accredited by the Accreditation Council for
Continuing Medical Education to provide continuing medical education for physicians.
UMDNJ – Center for Continuing and Outreach Education designates this educational activity for a
maximum of 10 AMA PRA Category 1 Credits™. Physicians should only claim credit commensurate with the
extent of their participation in the activity.
PEER REVIEW STATEMENT
This activity has been peer reviewed for relevance, accuracy of content and balance of presentation by Anita
Khilall, MPH
DISCLOSURE DISCLAIMER
In accordance with the disclosure policies of UMDNJ and to conform with ACCME and FDA guidelines,
individuals in a position to control the content of this education activity are required to disclose to the activity
participants: 1) the existence of any relevant financial relationship with any entity producing, marketing, reselling, or distributing health care goods or services consumed by, or used on, patients, with the exemption of
non-profit or government organizations and non-health care related companies, within the past 12 months;
and 2) the identification of a commercial product/device that is unlabeled for use or an investigational use of
a product/device not yet approved.
Financial Disclosure
The following faculty and planning committee members have stated that they have no significant financial
relationships to disclose:
Elissa Schechter-Perkins, MD
Sundari Mase, MD
John Jereb, MD
Alfred Lardizabal, MD
Chia-Ling Nhan-Chang, MD
Anne Fanning, MD
Eugenio Capitle, MD
Anita Khilall, MPH
Nisha Ahamed, MPH
Eileen Napolitano
Lee Reichman, MD, MPH has disclosed the following relevant financial relationships:
Consultant and Stock Shareholder – Cellestis, Inc.
Off-Label/Investigational Use Disclosure
This activity will include discussion of off label use of second and third-line drugs, including fluoroquinolones
for the treatment of multi-drug resistant tuberculosis, and short course therapy (12 doses of Isoniazid and
Rifapentine using directly observed therapy) for the treatment of latent TB infection.
This activity was peer-reviewed for relevance, accuracy of content, and balance of presentation.
CONTENT DISCLAIMER
The views expressed in this activity are those of the faculty. It should not be inferred or assumed that they
are expressing the views of any manufacturer of pharmaceuticals, or UMDNJ-Center for Continuing and
Outreach Education, NJMS Global TB Institute, or NYC Health Department. It should be noted that the
recommendations made herein with regard to the use of therapeutic agents, varying disease states, and
assessments of risk, are based upon a combination of clinical trials, current guidelines, and the clinical
practice experience of the participating presenters. The drug selection and dosage information presented in
this activity are believed to be accurate. However, participants are urged to consult the full prescribing
information on any agent(s) presented in this activity for recommended dosage, indications, contraindications,
warnings, precautions, and adverse effects before prescribing any medication.
COPYRIGHT
Copyright ©2011 UMDNJ-Center for Continuing and Outreach Education and NJMS Global Tuberculosis Institute.
All rights reserved including translation into other languages. No part of this activity may be reproduced or
transmitted in any form or by any means, electronic or mechanical, including photocopying, recording, or any
information storage and retrieval systems, without permission in writing from UMDNJ-Center for Continuing
and Outreach Education.